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Aims: To determine which risk factors for blindness were most critical in patients diagnosed 
with high tension primary open angle glaucoma (POAG) in a large ethnically diverse population 
managed with a uniform treatment strategy.
Methods: A longitudinal observational study was designed to follow 487 patients (974 eyes) 
with POAG for an average of 5.5 ± 3.6 years. Detailed ocular and systemic information was 
collected on each patient and updated every six months. For this study, blindness was deﬁ  ned 
as visual acuity of 20/200 or worse and/or visual ﬁ  eld less than 20° in either eye. Known risk 
factors were compared between patients with blindness in at least one eye versus nonblind 
patients.
Results: The patients with blindness had on average: higher intraocular pressure (IOP, 
mmHg): (24.2 ± 11.2 vs. 22.1 ± 7.7, p = 0.03), wide variation of IOP in the follow-up period 
(5.9 vs. 4.1 mmHg, p = 0.031), late detection (p = 0.006), poor control of IOP (p  0.0001), 
and noncompliance (p  0.0003). Other known risk factors such as race, age, myopia, family 
history of glaucoma, history of ocular trauma, hypertension, diabetes, vascular disease, smok-
ing, alcohol abuse, dysthyoidism, and steroid use were not signiﬁ  cant.
Conclusions: The most critical factors associated with the development of blindness among 
our patients were: elevated initial IOP, wide variations and poor control of IOP, late detection 
of glaucoma, and noncompliance with therapy.
Keywords: primary open angle glaucoma, blindness, intraocular pressure, risk factors, and 
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Introduction
The multifactorial and progressive nature of primary open angle glaucoma (POAG) 
is well established in regard to optic nerve damage and visual ﬁ  eld (VF) loss (Wilson 
et al 1982; O’Brien et al 1991; Hart et al 1997). Over time, 25% to 38% of patients 
exhibit signs of progression and ultimately blindness in one or both eyes (Wilson et al 
1982; O’Brien et al 1991; Hart et al 1997). A number of known risk factors associated 
with progression of vision loss and blindness in glaucoma patients is shown in Table 1 
(Reese and McGavic 1942; Harrington 1959; Spaeth 1971; Hiller and Kahn 1975; 
Harbin et al 1976; Kolker 1977; Drance et al 1978, 1981; Perkins 1978; Grant and 
Burke 1982; Leske 1983; Anderson 1989; O’ Brien et al 1991; Sommer et al 1991a, 
1991b; Araie et al 1994; Quigley et al 1994; Hattenhauer et al 1998; Gherghel et al 
2000; King et al 2000; Stewart et al 2000; The AGIS Investigators 2000; Kwan et al 
2001; Oliver et al 2002; Chen 2003).
However, it is not clear which of these factors are most important and which are 
inﬂ  uenced by variables such as fewer patients, short follow up, and ethnically non-
diverse patient population. To determine risk factors for progression to blindness, Clinical Ophthalmology 2008:2(4) 758
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we followed a large ethnically diverse patient population 
with high tension glaucoma over a long time frame. The 
primary outcome variable was the average percent of eyes 
that developed glaucoma-related blindness in either eye. 
Secondary outcome variables include sustained decrease of 
vision, progression of the disease, poor control, noncompli-
ance, late detection, and level of intraocular pressure (IOP). 
Features of patients who developed blindness were compared 
with those who did not. The underlying hypothesis was that 
certain risk factors in such a diverse study population were 
not signiﬁ  cant over the long term allowing us to identify the 
most critical clinical factors.
Materials and methods
Our cohort was selected from the patient population at an 
academic center, a county hospital, and a Veterans Affairs 
Hospital.
Legal blindness is deﬁ  ned in the US as visual acuity 
of 20/200 or worse and/or visual ﬁ  eld less than 20° in the 
better eye (Social Security Act 2006). Since this study 
was designed to follow individual eyes, this deﬁ  nition of 
blindness was modiﬁ  ed to refer to either eye rather than 
the better eye. The diagnosis of POAG included glaucoma-
tous optic nerve cupping with corresponding VF defects, 
IOP 21 mmHg and open irido-corneal angle (Klein et al 
1992; Dielemans et al 1994). Nine patients were blind in one 
eye at the start of the study. They were included because 
adequate long term information on the study variables 
were available. The exclusion criteria were: normal tension 
glaucoma (IOP  21 mmHg), secondary glaucoma, inability 
to maintain follow up for 3 months, eye conditions such as 
opaque media, macular degeneration, and vascular accidents 
that preclude diagnosis of glaucoma, and patients who were 
unable to perform ocular tests reliably. All eligible patients 
were examined and treated by the ﬁ  rst author or by the eye 
residents and glaucoma fellows under direct supervision. 
The study protocol was approved by the appropriate Institu-
tional Review Boards/Ethics Committees of the three clinics 
and adhered to the Declaration of Helsinki.
In all, 487 eligible patients (974 eyes) with POAG were 
enrolled in the study. The academic center (231 patients, 462 
eyes) is a private patient facility attached to the University 
of Texas Southwestern Medical Center at Dallas. Parkland 
Memorial Hospital is a county hospital (98 patients, 196 
eyes). The Dallas Veterans Affairs Hospital (158 patients, 
316 eyes) is a federal government facility for United States 
veterans.
Measured continuous and categorical variables at the 
conclusion of the study are summarized in Table 2.
For this study, VF changes were recorded as stages: 
1 = normal; 2 = relative scotoma outside 20º; 3 = absolute 
scotoma outside 20º; 4 = relative/absolute scotoma within 
20º–10º; 5 = relative/absolute scotoma within 10º–5º; 6 = 
relative/absolute scotoma within 5º in 1–3 quadrants, 7 = 
relative/absolute scotoma within 5º in all quadrants (Jay and 
Murray 1988). The criteria for VF abnormality on Humphrey 
Table 1 Risk factors for blindness in glaucoma
IOP
– Elevated IOP ( Harbin et al 1976; Kolker 1977;   Anderson 1989; O’Brien et al 1991;   Araie et al 1994; Quigley et al 1994; Gherghel et al 2000; King 
et al 2000; Stewart et al 2000; The AGIS Investigators 2000; Kwan et al 2001).
– Large diurnal variations (The AGIS Investigators 2000; Oliver et al 2002).
– Poor control of IOP (Oliver et al 2002).
– Mean IOP in the better eye (King et al 2000).
Older age (Quigley et al 1994; Hattenhauer et al 1998; Stewart et al 2000).
Advanced VF damage at diagnosis (Harrington 1959; Kolker 1977; Grant and Burke 1982; Leski 1983; Quigley et al 1994; Oliver et al 2002; Chen 2003).
Black American (Hiler and Kahn 1975; Sommer et al 1991a, 1991b).
Longer duration of disease (Grant and Burke 1982).
Noncompliance (Spaeth 1971; Grant and Burke 1982; Chen 2003).
Frequent disc hemorrhage (Drance et al 1981).
Late detection (Spaeth 1971; Perkins 1978; Grant and Burke 1982; Fraser et al 1999).
Worse vision (Grant and Burke 1982).
Vascular insufﬁ  ciency (Reese and McGavic 1942; Spaeth 1971; Drance et al 1978; Grant and Burke 1982; Gherghel et al 2000).
Family history of glaucoma (Drance et al 1978).
Greater number of antiglaucoma medications (Kwan et al 2001).
Glaucoma surgery (Kwan et al 2001).
Higher socioeconomic class (King et al 2000).
VF loss in the worse eye (King et al 2000).
Abbreviations: IOP, intraocular pressure; VF, visual ﬁ  eld.Clinical Ophthalmology 2008:2(4) 759
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program 30-2 full threshold strategy were a cluster of two 
or more adjacent points of 5-decibels (dB) or greater loss, 
and at least one of the points showing more than 10 dB loss 
according to the age corrected total deviation values. Every 
patient received one or more VF tests yearly. Optic nerve 
cupping was noted and drawn at baseline exam and at each 
visit. No photographs were taken. Any progression was 
ﬂ  agged and reconﬁ  rmed by KSK or the glaucoma fellow. 
Features of optic disk progression were; progression of C/D 
ratio by 0.2, rim notching and thinning from baseline, and 
disk hemorrhage. Noncompliance was based on documented 
nonadherance to therapy/surgery or from two or more missed 
clinic appointments during the observation period. Poor con-
trol of glaucoma was based on the following features: use of 
three or more medications, requirement of laser or incisional 
surgery, progression of C/D ratio by 0.2, or progression of 
VF from one stage to the next. Late detection was deﬁ  ned as 
C/D disparity of 0.2 or VF loss of stage 3 in one or both 
eyes at initial presentation.
Categorical variables (such as gender, procedures, 
medications) of blindness and no-blindness groups were com-
pared with the Fisher’s Exact Test or Chi-square statistics. 
Continuous variables (such as age, C/D ratio) were compared 
between groups with two-sample t-tests or Wilcoxon Rank 
Sum tests if normality assumptions were not met. Logistic 
regression models were used to assess multiple risk factors 
simultaneously. Data management was performed using 
Microsoft Access 97 and 2000 (Microsoft Corp. Redmond, 
WA). For statistical analysis, SAS version 8.0 (SAS Institute, 
Cary, NC) was used.
Results
At the end of the study, there were 282 (57.9%) nonblind 
patients and 205 (42.1%) blind patients. Of the total number 
of patients, 195 were diagnosed initially at one of the three 
study clinics. In the blind group, 120 (58.5%) had bilateral 
blindness while 85 (41.5%) had unilateral blindness. Table 2 
lists the main characteristics of the groups.
Table 2 Demographics and characteristics of composite patient population: No blindness versus blindness
Characteristics  No blindness n (%) 282  Blindness n (%) 205  p value
Age at diagnosis, yr (mean ± SD, median, range)  59.0 ± 12.6, 59.4,  59.3 ± 13.2, 61.1, 
 21.2–86.9  28.8–90.4  0.52
Follow-up, yr (mean ± SD, median, range)  5.1 ± 3.1, 4.2,  6.1 ± 4.0, 5.2, 
 1.0–18.1  0.3–23.7  0.04
Male 151  (53.5)  139  (67.8)  p   0.002
Female  131 (46.4)  66 (32.2) 
Caucasian 124  (44.0)  69  (33.7) 
Black American  134 (47.4)  119 (58.1) 
Hispanic 12  (4.3)  7  (3.4) 
Other ethnicities  12 (4.3)  10 (4.8) 
Ocular surgeries     
Cataract 52  (18.4)  48  (23.4)  0.211
ALT  92 (32.6)  89 (43.4)  0.020
LPI 29  (10.3)  31  (15.2)  0.124
Trabeculectomy  28 (9.9)  60 (29.3)  0.0001
Combined 22  (7.8)  18  (8.8)  0.740
Cyclodestruction 0  (0.0)  9  (4.4)  0.0004
Others 14  (5.0)  16  (7.8)  0.252
Visual acuity Deterioration  36 (12.7)  82 (40.0)  0.0001
VF progression  46 (16.3)  47 (22.9)  0.10
IOP mmHg (mean ± SD, median, range)     
Initial visit  22.1 ± 7.7, 21.0,  24.2 ± 11.2, 21.0,  0.030
 2–70  2.0–70.0 
Final visit  18.1 ± 2.4, 18.0,  17.7 ± 4.8, 18.0,  0.153
 10.0–26.0  0.0–46.0 
C/D ratio progression  92 (32.6)  55 (26.8)  0.20
Noncompliance 131  (46.4)  129  (63.0)  0.0003
Poor control  207 (73.4)  196 (95.6)  0.0001
Late detection  248 (87.9)  195 (95.1)  0.006
Notes: Blindness was deﬁ  ned as visual acuity of 20/200 or worse and/or visual ﬁ  eld less than 20° in either eye.
Abbreviations: ALT, argon laser trabeculoplasty; LPI, laser peripheral iridotomy; CF, count ﬁ  ngers; HM, hand motion; LP, light perception; NLP, no light perception; VF, visual 
ﬁ  eld; IOP, intraocular pressure; C/D, cup-to-disc; CAI, carbonic anhydrase inhibitor.Clinical Ophthalmology 2008:2(4) 760
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At baseline, the blind group had statistically signiﬁ  cant 
higher IOP than the nonblind group (24.2 vs. 22.1 mmHg; 
p = 0.03). They also showed wide ﬂ  uctuations (maximum 
to minimum IOP) over the course of the study (5.9 mmHg 
vs. 4.1 mmHg, p = 0.031). The mean IOP for each patient in 
both groups is shown in Figure 1.
At pressure of 17 mmHg or less, 54 (26.3%) patients were 
blind. Pressure levels gradually decreased in both groups over 
time, but the standard deviation of individual IOP was still 
higher in the blind group (4.8 vs. 2.4 mmHg, p = 0.02).
Blind patients required more laser (43.4%), trabecu-
lectomy (29.3%), and cyclodestruction (4.4%) procedures. 
Their vision at initial visit was also worse, with 76 (37%) 
recording vision 20/200 and only 93 (45.4%) showing 
vision of 20/40 compared with 261 (92.5%) of the non-
blind group. By the last visit, 82 (40%) of blind subjects 
experienced deterioration of vision and 115 (56%) had 
dropped to 20/200. In comparison, only 36 (12.7%) of the 
nonblind group showed progression.
In blind individuals, the VF status at initial visit was: mild 
damage (stage 1 and 2) in 29 (14.2%); moderate damage 
(stage 3 and 4) in 49 (23.9%); and severe damage (stage 5 to7) 
in 127 (61.9%). At the ﬁ  nal visit the values were 17 (8.3%), 
41 (20.0%), and 147 (71.7%), respectively. VF deterioration 
occurred in 46 (16.3%) of nonblind group and 47 (22.9%) 
of blind group.
As expected, optic nerve appearance was worse in the 
blind group at ﬁ  rst visit, with 154 (75%) of patients showing 
C/D of 0.7 compared with 102 (36.2%) in the nonblind 
group. This ﬁ  gure reached 175 (85.4%) and 132 (46.8%) 
at the last visit, respectively. Both groups exhibited dete-
rioration of optic nerve features. Similarly, noncompliance, 
inadequate control and late detection were higher in blind 
subjects. Baseline IOP, female gender, and baseline VF were 
signiﬁ  cant risk factors for blindness (Table 3).
Other risk factors such as race, age, history of hyperten-
sion, diabetes, vascular disease, family history of glaucoma, 
smoking, alcohol abuse, systemic or topical steroids dysthy-
roidism, ocular trauma (all variables obtained by history) and 
myopia, were not signiﬁ  cant.
Discussion
Our ﬁ  ndings support the widely held belief that IOP is still of 
paramount importance in management of glaucoma (Harbin 
et al 1976; Kolker 1977; Anderson 1989; O’Brien et al 1991; 
Araie et al 1994; Quigley et al 1994; Gherghel et al 2000; 
King et al 2000; Stewart et al 2000; The AGIS Investigators 
2000; Kwan et al 2001; Oliver et al 2002). Blind patients in 
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Figure 1 Prevalence of blindness in relation to intraocular pressure. Blindness was prevalent at all levels of intraocular pressure. 26.3 % of patients were blind at pressures 
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our study had higher level of initial IOP, more ﬂ  uctuations 
in pressure, and were difﬁ  cult to control. Blindness and 
progression of glaucoma was evident at all pressure levels 
(Figure 1). This ﬁ  nding is in contrast to the Advanced Glau-
coma Intervention Study (AGIS) where progression was 
minimal in patients with IOP less than 18 mmHg. The AGIS 
investigators found that VF progression was less if a patient 
maintained IOP of less than 18 mmHg at each visit, but their 
patients had advanced glaucoma based on medical therapy 
where as this study had patients in all stages of the disease 
(The AGIS Investigators 2000). At the ﬁ  nal visit 116 (57%) 
patients had IOP 21 mmHg. Why did so many patients 
have elevated mean IOP? There may be several explanations. 
First, some patients become noncompliant or exhibit poor 
response to therapy. Second, after an eye shows advanced 
VF loss such as split ﬁ  xation, there is hesitancy to reduce 
IOP surgically for fear of “snufﬁ  ng out” the remaining ﬁ  bers 
(Kolker 1977). Third, when the visual acuity drops to HM or 
worse, IOP reduction becomes less of a priority compared 
with keeping the patient comfortable.
Similar to the ﬁ  ndings of Kwan and colleagues (2001) 
our blind patients also required multiple medications and 
more laser and incisional surgeries. Subjects with blindness 
also presented with advanced visual acuity loss, VF loss, and 
optic nerve damage. Therefore, late detection was a signiﬁ  cant 
risk factor. Moreover, a multivariate analysis using logistic 
regression to model the probability of blindness demonstrated 
that baseline elevated IOP and advanced VF damage were 
signiﬁ  cant risk factors. Of those who were initially diagnosed 
with POAG at one of the three study clinics, blindness was 
detected at the ﬁ  rst visit in 21.7%, which was similar to other 
studies (Perkins 1978; Grant and Burke 1982; Konstas et al 
2000). Several investigators have pointed out the role played 
by advanced VF damage at diagnosis (Harrington 1959; Harbin 
et al 1976; Kolker 1977; Quigley et al 1994; King et al 2000; 
Oliver et al 2002; Chen 2003), degree of VF loss in the worst 
eye (King et al 2000), and vascular insufﬁ  ciency (Reese and 
McGavic 1942; Spaeth 1971; Drance et al 1978; Gherghel et al 
2000). The progressive nature of POAG was evidenced by VF 
deterioration. Both noncompliance to treatment and inadequate 
control were more prevalent in blind patients. The signiﬁ  cance 
of noncompliance with treatment has been stressed by several 
investigators (Drance et al 1978; Kostas et al 2000). One weak-
ness of the study is that the central corneal thickness was not 
measured because of the unavailability of measuring devices 
at the three centers. The authors understand the pivotal role 
central corneal thickness may play in the development and 
progression of glaucoma (Gordon et al 2002).
In conclusion, we followed 487 ethnically diverse patients 
with high tension POAG in a single metropolitan area and 
with a uniform management strategy for over 5 years. Risk 
factors for blindness were mainly pressure-elated: elevated 
initial IOP, wide variations and poor control of IOP, late 
detection of glaucoma, and noncompliance with therapy. 
Other known factors such as older age (Quigley et al 1994; 
Hattenhauer et al 1998; Stewart et al 2000), black American 
(Sommer et al 1991a; Hiller and Kahn 1975), vascular insuf-
ﬁ  ciency (Reese and McGavic 1942; Spaeth 1971; Drance 
et al 1978; Grant and Burke 1982; Gherghel et al 2000), or 
family history of glaucoma (Drance et al 1978) were not 
signiﬁ  cant. Our results suggest that further studies with 
larger diverse populations and longer follow are required to 
verify these ﬁ  ndings and to better understand the dynamics 
of glaucoma progression.
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